SCPH insider filings

scPharmaceuticals Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-10-07. Screen SCPH transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for SCPH between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — scPharmaceuticals Inc.

FiledFormInsiderReported transactionsSource
2025-10-074Abraham William Tober — DirectorDisposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0EDGAR
2025-10-074Baylor-Henry Minnie — DirectorDisposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0 · Disposition to issuer (D): 6,124 (derivative) @ $0 · Disposition to issuer (D): 12,248 (derivative) @ $0EDGAR
2025-10-074Nokes Rachael — CFO and TreasurerCode (U): 30,386 · Disposition to issuer (D): 125,675 · Disposition to issuer (D): 132,670 (derivative) @ $0 · Disposition to issuer (D): 54,700 (derivative) @ $0 · Disposition to issuer (D): 6,426 (derivative) @ $0 · Disposition to issuer (D): 13,850 (derivative) @ $0EDGAR
2025-10-074Agger Mette Kirstine — DirectorDisposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0EDGAR
2025-10-074Bonstein Sara — DirectorDisposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0EDGAR
2025-10-074Khattar Jack A. — DirectorCode (U): 5,000 · Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0 · Disposition to issuer (D): 6,124 (derivative) @ $0EDGAR
2025-10-074Hudson Frederick M. — DirectorDisposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0 · Disposition to issuer (D): 6,124 (derivative) @ $0EDGAR
2025-10-074Tucker John H — President and CEO, DirectorCode (U): 122,345 · Disposition to issuer (D): 318,502 · Disposition to issuer (D): 300,000 (derivative) @ $0 · Disposition to issuer (D): 84,500 (derivative) @ $0 · Disposition to issuer (D): 249,000 (derivative) @ $0 · Disposition to issuer (D): 496,674 (derivative) @ $0EDGAR
2025-10-074VEITINGER KLAUS R DR — DirectorDisposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0 · Disposition to issuer (D): 6,124 (derivative) @ $0EDGAR
2025-10-074SCHAEFFER LEONARD D — DirectorCode (U): 68,796 · Code (U): 43,104 · Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0EDGAR
2025-06-054Agger Mette Kirstine — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2025-06-054Baylor-Henry Minnie — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2025-06-054Abraham William Tober — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2025-06-054Bonstein Sara — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2025-06-054Khattar Jack A. — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2025-06-054Hudson Frederick M. — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2025-06-054VEITINGER KLAUS R DR — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2025-06-054SCHAEFFER LEONARD D — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2025-02-124Nokes Rachael — CFO and TreasurerGrant/award (A): 88,445 @ $0 · Grant/award (A): 132,670 (derivative) @ $0EDGAR
2025-02-124Tucker John H — President and CEO, DirectorGrant/award (A): 200,000 @ $0 · Grant/award (A): 300,000 (derivative) @ $0EDGAR
2025-01-074Nokes Rachael — CFO and TreasurerTax withholding (F): 5,235 @ $3.56EDGAR
2025-01-074Tucker John H — President and CEO, DirectorTax withholding (F): 13,360 @ $3.56EDGAR
2024-08-284/ANokes Rachael — CFO and TreasurerOption exercise (M): 10,445 @ $1.66EDGAR
2024-08-284SCHAEFFER LEONARD D — DirectorOption exercise (M): 5,223 @ $1.66 · Option exercise (M): 6,124 @ $3.37 · Option exercise (M): 5,223 (derivative) @ $0 · Option exercise (M): 6,124 (derivative) @ $0EDGAR
2024-08-154ORBIMED ADVISORS LLC — 10% owner
OrbiMed Capital GP VI LLC — 10% owner
OrbiMed Genesis GP LLC — 10% owner
Purchase (P): 478,342 @ $4 · Purchase (P): 21,658 @ $4EDGAR
2024-08-084Nokes Rachael — CFO and TreasurerOption exercise (M): 10,445 @ $0 · Option exercise (M): 10,445 (derivative) @ $0EDGAR
2024-06-134Agger Mette Kirstine — DirectorGrant/award (A): 19,750 (derivative) @ $0EDGAR
2024-06-134Abraham William Tober — DirectorGrant/award (A): 19,750 (derivative) @ $0EDGAR
2024-06-134Baylor-Henry Minnie — DirectorGrant/award (A): 19,750 (derivative) @ $0EDGAR
2024-06-134Bonstein Sara — DirectorGrant/award (A): 19,750 (derivative) @ $0EDGAR
2024-06-134Khattar Jack A. — DirectorGrant/award (A): 19,750 (derivative) @ $0EDGAR
2024-06-134Hudson Frederick M. — DirectorGrant/award (A): 19,750 (derivative) @ $0EDGAR
2024-06-134VEITINGER KLAUS R DR — DirectorGrant/award (A): 19,750 (derivative) @ $0EDGAR
2024-06-134SCHAEFFER LEONARD D — DirectorGrant/award (A): 19,750 (derivative) @ $0EDGAR
2024-04-024Tucker John H — President and CEO, DirectorGrant/award (A): 56,025 (derivative) @ $0EDGAR
2024-01-224Nokes Rachael — CFO and TreasurerGrant/award (A): 41,840 @ $0 · Grant/award (A): 62,755 (derivative) @ $0EDGAR
2024-01-224Tucker John H — President and CEO, DirectorGrant/award (A): 113,560 @ $0 · Grant/award (A): 170,340 (derivative) @ $0EDGAR
2024-01-034Nokes Rachael — CFO and TreasurerTax withholding (F): 1,027 @ $6.39EDGAR
2024-01-034Tucker John H — President and CEO, DirectorTax withholding (F): 4,942 @ $6.39EDGAR
2023-06-084Baylor-Henry Minnie — DirectorGrant/award (A): 17,300 (derivative) @ $0EDGAR
2023-06-084Agger Mette Kirstine — DirectorGrant/award (A): 17,300 (derivative) @ $0EDGAR
2023-06-084Abraham William Tober — DirectorGrant/award (A): 17,300 (derivative) @ $0EDGAR
2023-06-084Bonstein Sara — DirectorGrant/award (A): 17,300 (derivative) @ $0EDGAR
2023-06-084Khattar Jack A. — DirectorGrant/award (A): 17,300 (derivative) @ $0EDGAR
2023-06-084Hudson Frederick M. — DirectorGrant/award (A): 17,300 (derivative) @ $0EDGAR
2023-06-084VEITINGER KLAUS R DR — DirectorGrant/award (A): 17,300 (derivative) @ $0EDGAR
2023-06-084SCHAEFFER LEONARD D — DirectorGrant/award (A): 17,300 (derivative) @ $0EDGAR
2023-01-234Nokes Rachael — See RemarksTax withholding (F): 1,981 @ $10.09 · Tax withholding (F): 1,976 @ $7.27 · Grant/award (A): 11,700 @ $6.14 · Grant/award (A): 17,550 (derivative) @ $0EDGAR
2023-01-234Tucker John H — President and CEO, DirectorGrant/award (A): 66,665 @ $6.14 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-12-194Nokes Rachael — See RemarksGrant/award (A): 85,750 (derivative) @ $0EDGAR

Recent 8-K events — scPharmaceuticals Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2025-10-078-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2025-09-248-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-258-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-258-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-06-098-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-05-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-03-198-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-01-108-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-12-118-K7.01 — Regulation FD DisclosureEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=SCPH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs